Authors: VIGNETTI M IACOPINO P TRASARTI S MESSINA G BARBUI T CARELLA AM ALESSANDRINO PP BENEDETTI F FALDA M SAJEVA MT CARLOSTELLA C LAMBERTENGHI G SICA S VISANI G MELONI G

Citation: M. Vignetti et al., OUTCOME OF ACUTE MYELOID-LEUKEMIA (AML) RELAPSING AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN FIRST REMISSION, Bone marrow transplantation, 21, 1998, pp. 13-13

Authors: MELONI G CAPRIA S PROIA A TRASARTI S TRISOLINI SM MANDELLI F

Citation: G. Meloni et al., ABMT FOR CML IN BLASTIC CRISIS AND LONG-LASTING SLE - 3 YEARS REMISSION OF BOTH DISEASES, Bone marrow transplantation, 21, 1998, pp. 304-304

Authors: TRASARTI S MELONI G CAPRIA S BONGARZONI V FERRAZZA G IODICE F PROIA A TRISOLINI SM MANDELLI F

Citation: S. Trasarti et al., HIGH-DOSE IDARUBICINE, BUSULFAN AND MELPHALAN CONDITIONING REGIMEN FOR LYMPHOPROLIFERATIVE DISORDERS, Bone marrow transplantation, 21, 1998, pp. 352-352

Authors: CARLOSTELLA C TABILIO A REGAZZI E GARAU D LATAGLIATA R TRASARTI S ANDRIZZI C VIGNETTI M MELONI G

Citation: C. Carlostella et al., EFFECT OF CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA ON HEMATOPOIETIC AND FIBROBLAST MARROW PROGENITORS, Bone marrow transplantation, 20(6), 1997, pp. 465-471